STEMI INDIA 2014

SPEAKERS

The outstanding faculty for the meeting will include some of the pioneers in
STEMI management from across the world and India.

INTERNATIONAL FACULTY

NATIONAL FACULTY

Asst. Prof. Petr Kala, MD,PhD,FESC,FSCAI

SFL Chairman, Czech Society of Cardiology

Dr. Jagat Narula

Associate Dean for Global Affairs
Professor of Medicine

Dr. Umesh Khot

Vice Chairman - Cardiovascular Medicine,
Cleveland Clinic

Dr. Venu Menon

Director -Coronary Care Unit,
Cleveland Clinic

Dr. Zuzana Kaifoszova

Project Manager - SFL, Europe,
Czech Republic

Dr. Anuj Gupta

Director - Cardiac Cath Lab
University of Maryland School of Medicine

Dr. Dinesh Shah, MD, FACC

CEO & Medical Director,
Michigan Physicians Group, Berkley, MI

Dr. Gotabhaya Ranasinghe, MBBS, MD, FCCP, FRCP, FAPSIC, FACC

General and Interventional Cardiologist,
The President, Sri Lanka Heart Association

Dr. Dharam Kumbhani

Assistant Professor, Interventional Cardiology,
UT Southwestern Medical Center

Asst. Prof. Petr Kala,MD,PhD,FESC,FSCAI
Stent for Life (SFL) Chairman,
Czech Society of Cardiology

The aim of the Stent for Life Initiative (SFL) is to improve the nationwide care of patients suffering acute heart attack in Europe and beyond. SFL is supported by key interventional cardiologists from many countries where STEMI network should or has been established. Petr, Asst. Prof. at the Medical Faculty of Masaryk University in Brno, Czech Republic, has been involved in SFL from its beginning in 2009 by sharing his exceptional practice experience in interventional cardiology, research and education.

He is a Chairman of Stent for Life (SFL), board member of EAPCI and Past President of the WG of Interventional Cardiology of the Czech Society of Cardiology.

Dr. Jagat Narula
Associate Dean for Global Affairs
Professor of Medicine

Jagat Narula, MD, PhD, MACC is Professor of Medicine and Philip J. and Harriet L. Goodhart Chair in Cardiology, and the Director of Cardiovascular Imaging Program in Mount Sinai's Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. He is the Associate Dean for Global Health at the Icahn School of Medicine at Mount Sinai.

In 1989, upon finishing his cardiology fellowship training and PhD (Cardiovascular Immunology) from the All India Institute of Medical Sciences - Delhi, Dr. Narula relocated to Massachusetts General Hospital (MGH) and Harvard Medical School. At MGH, he completed cardiology, heart failure & transplantation, and nuclear cardiology fellowships and then joined the cardiology faculty. In 1997, he moved to Hahnemann University Schoolof Medicine, Philadelphia, where he was Thomas J. Vischer Professor of Medicine, Chief of the Division of Cardiology, Vice-Chairman of the department of Internal Medicine, and Director of Heart Failure & Transplantation Center. He subsequently joined University of California, Irvine School of Medicine (2003) as Chief of the Division of Cardiology, Associate Dean for Research, and Director of the Cardiovascular Center of the UC Irvine's Douglas Hospital. He was also the Director of Memorial Heart & Vascular Institute, Long Beach Memorial Hospital, and Medical Director of the Edwards Lifesciences Center for Advanced Cardiovascular Technology in UC Irvine's Henry Samueli School of Engineering.

Dr. Narula has the unique distinction of being able to combine molecular and subcellular pathology and imaging with clinical imaging of the failing myocardium and high-risk coronary atherosclerotic plaques to develop novel strategies for prevention of cardiovascular disease and promotion of cardiovascular health in developed as well as developing countries. He has specifically contributed to two major areas including heart muscle cell apoptosis in heart failure, and lipid-rich atherosclerotic plaques that are susceptible to rupture and acute coronary events. He has brought novel experimental strategies to bedside and defined their applicability at the community level. He is the Editor-in-Chief of the Journal of American College of Cardiology: Cardiovascular Imaging. He is also the Editor-in-Chief of Global Heart (the official Journal of World Heart Federation). He is currently actively involved in population-based heart attack prevention programs including HAPPY [Heart Attack Prevention Program for You]. He has served on the Advisory Council on Global Prevention of Cardiovascular Diseases of the Institute of Medicine of the National Academies of Sciences.

His research has been funded, in part, by the grants from National Institutes of Health. He is considered to be a true translationist and one of the infrequent investigators who has the distinction of publishing in the best basic science and the best clinical journals including Science, Nature Medicine, PNAS, New England Journal of Medicine, Lancet, Circulation and JACC. With more than 800 original research publications or presentations to his credit and more than 30 books or journal supplements edited, Dr. Narula has been awarded as 'the best young investigator' on several occasions for his research contributions. His mentoring prowess is exemplified by the fact that 20 of his fellows, working in his research laboratory, have been awarded young investigator awards; he was recently awarded as the Best Educator by the American College of Cardiology. He was also announced as one of the five Innovators in Cardiovascular Medicine in the year 2012, and was honored as the Master of the American College of Cardiology in March 2013.

Dr. Anuj Gupta
Director, Cardiac Cath Lab
University of Maryland School of Medicine

Anuj Gupta, MD, FACC, FSCAI is an interventional cardiologist and the directorof the Cardiac Catheterization Laboratory at the University of Maryland School of Medicine. A graduate of the Johns Hopkins University, he completed his training in cardiology under Alfred Bove, MD (former President of the American College of Cardiology) at Temple University Hospital and his interventional cardiology at Columbia University Medical Center. In addition to being the site principal investigator in the PARTNER 2A Trial and the SYMPLICITY HTN-3 Trial, he is a sub-investigator on a variety of trials, including the ISCHEMIA Trial.

He is the Secretary and Governor- Elect of the Maryland Chapter of the American College of Cardiology, as well as a member of the Maryland Cardiac Data Committee. He is also a principal in the Maryland Academic Consortium for Percutaneous Coronary Intervention Appropriateness and Quality), a joint initiative between Johns Hopkins Hospital and the University of Maryland Medical Center to create a system of external peer review for PCI in the state of Maryland.

Dr. Umesh Khot
Vice Chairman - Cardiovascular Medicine,
Cleveland Clinic

Dr. Umesh N. Khot, MD, is a Vice Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine within the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. His clinical specialties include coronary artery disease, heart attack care, heart valve disease and heart failure. He is board-certified in cardiovascular medicine, echocardiography and nuclear cardiology.

Dr. Khot is the author of a number of research articles in leading medical journals, including The New England Journal of Medicine, Journal of the American Medical Association (JAMA), Journal of the American College of Cardiology and Circulation. He has contributed to novel understanding of the role of vasodilator therapy in severe aortic stenosis, the association between risk factors and heart disease, and insights into outcomes in patients with heart failure and heart surgery. His research has been cited within the practice guidelines of the American College of Cardiology, American Heart Association, and European Society of Cardiology.

Dr. Venu Menon
Director -Coronary Care Unit,
Cleveland Clinic

Dr. Venu Menon, MD, is a staff cardiologist in the Section of Cardiovascular Imaging and Director of the Coronary Care Unit in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is also a Director of the Cardiovascular Fellowship Program and Associate Director of C5 ( Cleveland Clinic Coordinating Center for Clinical Research). He is board-certified in internal medicine, cardiovascular diseases, nuclear cardiology and echocardiography. His specialty interests include critical care cardiology, cardiovascular imaging, echocardiography and valve disease and the conduct of clinical trials.

Dr. Menon received his medical degree from the J.I.P.M.E.R. Medical School, Madras University in Pondicherry, India. He took an internship in internal medicine at St. Luke's-Roosevelt Hospital, College of Physician and Surgeons, in New York, where he received the Chief Resident's Award as well as the Michael Rauchman award for best graduating resident. He went on to complete his fellowship training in cardiovascular disease, and continued his research training as a Clinical Research Fellow on the NIH-supported SHOCK Trial.

Dr. Menon has held several academic appointments. He was an Assistant Professor of Clinical Medicine at Columbia College of Physicians and Surgeons, and Assistant Professor of Medicine and Assistant Professor of Emergency Medicine at the University of North Carolina School of Medicine. He was the recipient of the Distinguished Faculty Award as Outstanding Teacher of the Year (2001-2002) while in New York. During his tenure at UNC School of Medicine, he was named Educator of the Year and was inducted into the Alpha Omega Alpha Medical Honor Society.

Prior to his 2005 appointment to Cleveland Clinic as Staff Cardiologist, Dr. Menon was a Director of the Coronary Care Unit and Director of the Chest Pain Unit at the University of North Carolina Hospitals. Prior to this appointment, he was an Assistant Director of Cardiac Research at St. Luke's-Roosevelt Hospital Center. Dr. Menon is a reviewer for the American Heart Journal, the American Journal of Cardiology, the European Heart Journal, Journal of the American College of Cardiology, Heart and the American Journal of Medicine.

His research interests have focused on early revascularization for cardiogenic shock as well as the late open artery hypothesis. He has published his research in leading peer-reviewed medical journals. He has edited, authored or co-authored textbooks and chapters in medical textbooks on chronic coronary artery disease, noninvasive cardiac testing and accute coronary syndromes. He has been invited to lecture on his specialty interests throughout the United States and internationally.

Dr. Menon is a fellow of the American College of Cardiology and the American Heart Association.

Dr. Zuzana Kaifoszova
Project Manager - SFL, Europe,
Czech Republic

Dr. Zuzana Kaifoszova, M.D., MBA graduating from the Medical Faculty of the Charles University in Prague in 1982 began practicing medicine at the Faculty Hospital "Royal Vineyards" in Prague and is certified in internal diseases. In 1992 Zuzana decided to leave her medical practice and joined the pharmaceutical industry. Zuzana had then worked in different senior management positions for more than 17 years on national and regional levels including the US at major pharmaceutical, medical device and biotechnology companies.

Zuzana is a proud executive MBA graduate from Thunderbird School of Global Management. Her passion to pioneer new projects, work with different stakeholders and influence the healthcare environment thus bringing innovation to patients, led her to a decision to accept the invitation to design the Stent for Life Initiative (SFL) in Europe; one of the most exciting projects of her life. Currently 18 cardiac societies and affiliated organizations in Europe and Asia actively participate in SFL in order to shape healthcare environment and thus increase STEMI patients' access to a life saving indication of primary-PCI.

Motto: Gaining Access to Innovation. Building Coalitions. Saving Lives.

Dr. Anuj Gupta
Director - Cardiac Cath Lab
University of Maryland School of Medicine

Anuj Gupta, MD, FACC, FSCAI is an interventional cardiologist and the director of the Cardiac Catheterization Laboratory at the University of Maryland School of Medicine. A graduate of the Johns Hopkins University, he completed his training in cardiology under Alfred Bove, MD (former President of the American College of Cardiology) at Temple University Hospital and his interventional cardiology at Columbia University Medical Center. In addition to being the site principal investigator in the PARTNER 2A Trial and the SYMPLICITY HTN-3 Trial, he is a sub-investigator on a variety of trials, including the ISCHEMIA Trial.

Dr. Dinesh Shah, MD, FACC
CEO & Medical Director,
Michigan Physicians Group, Berkley, MI

Dr. Dinesh Shah MD, FACC is CEO & Medical Director, Michigan Physicians Group, Berkley, MI, Medical Director, Envision Scientific and co-inventor of First in the world Polymer free drug eluding stent (nanotechnology coated stent that converts to bare metal in 8 months), Medical Director, Concept Medical and CMO of First and only one in the world drug eluding balloon (working with world‐renowned PE Firm to bring technology to USA).

He is the Co-Founder and Medical Director, Real3D - Developing next generation materials for medical applications using 3D Printing (Polymer based materials for FDM, and SLA), Founder & Chairperson, Global Care Foundation and Board Member, Geetmala Foundation of Michigan.

His board certifications include American Board of Interventional Cardiology (through 2018), American Board of Cardiovascular Disease, Diplomate (through 2017) and American Board of Internal Medicine, Diplomate (1988).

His current affiliation is with Beaumont Hospital, Royal Oak, MI.

Dr. Gotabhaya Ranasinghe, MBBS, MD, FCCP, FRCP, FAPSIC, FACC
General and Interventional Cardiologist,
The President, Sri Lanka Heart Association

Dr. Gotabhaya Ranasinghe is a consultant in Clinical and Interventional Cardiology and an Honorary Consultant Cardiologist to the Sri Lanka Navy holding the rank of Surgeon Commodore. He is a fellow of Ceylon College of Physicians (FCCP – 2009), Royal College of Physicians (FRCP – 2012), Asia Pacific Society of Interventional Cardiology (FAPSIC – 2013) and American College of Cardiology (FACC - 2013). He became a board certified Cardiologist in 2001 and completed a Fellowship in Clinical and Interventional Cardiology at John Radcliff Hospital in Oxford, United Kingdom. During his more than 10 years as a specialist he has performed more than 9,000 cardiac procedures. He has spoken and been on the faculty of many local and regional Cardiac and Intervention meetings and published two booklets. His main interest being ST segment Elevation Myocardial Infarction (STEMI), he aims to optimize STEMI care in the country during his tenure as the SLHA president by introducing newer thrombolytic agents as well as increasing the primary PCIs for acute STEMI management.

Dr. Dharam Kumbhani
Assistant Professor, Interventional Cardiology
UT Southwestern Medical Center

Dr. Dharam J. Kumbhani, MD, SM, MRCP, FACC, FAHA, FSCAI is currently Assistant Professor of Medicine in the Division of Cardiology at the University of Texas Southwestern Medical Center in Dallas, Texas. He is an interventional cardiologist, and his practice specializes in transradial and complex coronary interventions, transcatheter aortic valve implantation, endovascular interventions and adult structural heart disease interventions.

Dr. Kumbhani received his medical doctorate from Grant Medical College/Sir J. J. Group of Hospitals with Distinction. He completed a Masters in Science with a concentration in clinical epidemiology at Harvard University. His internship and residency in internal medicine were performed at the Hospital of the University of Pennsylvania, and his cardiovascular training was at Cleveland Clinic. He completed fellowships in interventional cardiology, advanced structural and endovascular interventions, as well as a postdoctoral research fellowship at the Brigham and Women's Hospital and Harvard Medical School, where he was also Instructor in Medicine/Cardiology.

Dr. Kumbhani is an internationally recognized name in the field of outcomes-based and quality-of-care research. His research particularly focuses on acute coronary syndromes, percutaneous coronary interventions, and peripheral vascular disease. He has authored or co-authored more than 60 articles in medical journals such as JAMA, JACC and Circulation. He has received numerous awards and grants for his research. Dr. Kumbhani is an elected member of the American College of Epidemiology, the Sigma Xi Research Society and the Royal College of Physicians, UK. He currently serves on the Editorial Board of Cardiosource for the American College of Cardiology (ACC) and the Get With the Guidelines Scientific Committee and Coronary Artery Disease clinical work group of the American Heart Association (AHA). He is a core member of the ACC Task Force on Clinical Expert Consensus Documents.